BIOMAT Database Logo BIOMAT Database Logo

Diabetes insipidus associated with Wegener's granulomatosis successfully treated with cyclophosphamide. 1978

B F Haynes, and A S Fauci

UI MeSH Term Description Entries
D008297 Male Males
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003919 Diabetes Insipidus A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014890 Granulomatosis with Polyangiitis A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. Granulomatosis, Wegener's,Wegener Granulomatosis,Wegener's Granulomatosis,Granulomatosis with Polyangiitides,Granulomatosis, Wegener,Polyangiitides, Granulomatosis with,Polyangiitis, Granulomatosis with,with Polyangiitides, Granulomatosis,with Polyangiitis, Granulomatosis

Related Publications

B F Haynes, and A S Fauci
Cyclophosphamide treatment of diabetes insipidus in Wegener's granulomatosis.
February 1979, The New England journal of medicine,
B F Haynes, and A S Fauci
Cyclophosphamide-intolerant Wegener's granulomatosis successfully treated with mycophenolate mofetil.
January 2008, Acta reumatologica portuguesa,
B F Haynes, and A S Fauci
[Wegener's granulomatosis treated with cyclophosphamide].
April 1973, Nederlands tijdschrift voor geneeskunde,
B F Haynes, and A S Fauci
[Wegener's granulomatosis causing diabetes insipidus].
August 1982, Fortschritte der Medizin,
B F Haynes, and A S Fauci
Wegener's granulomatosis and diabetes insipidus.
July 1999, Rheumatology (Oxford, England),
B F Haynes, and A S Fauci
Bronchocentric granulomatosis and central diabetes insipidus successfully treated with corticosteroids.
October 1994, The European respiratory journal,
B F Haynes, and A S Fauci
Wegener's granulomatosis presenting as diabetes insipidus.
October 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
B F Haynes, and A S Fauci
[Cranial diabetes insipidus in Wegener's granulomatosis].
March 2006, Ugeskrift for laeger,
B F Haynes, and A S Fauci
Wegener's granulomatosis complicated by diabetes insipidus.
October 1983, Annals of the rheumatic diseases,
B F Haynes, and A S Fauci
[Severe Wegener's granulomatosis successfully treated with rituximab].
January 2010, Terapevticheskii arkhiv,
Copied contents to your clipboard!